About Crescent Bioformulations Private Limited
Data last updated:
Crescent Bioformulations Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 11 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2011PTC046931. Its GSTIN is 09AAECC6231G1ZT (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹76.28 Lakh. It is led by directors including Anurag Bajpai and Anurag Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 119/135 Darshan Purwa, Kanpur, Uttar Pradesh, India – 208012.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.47 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹3,000 (net margin 0%) and EBITDA of ₹71.65 Lakh (EBITDA margin 13.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹2.14 Cr and satisfied charges of ₹4.64 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website crescentbioformulations.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address119/135 Darshan Purwa, Kanpur, Uttar Pradesh, India – 208012
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Crescent Bioformulations Private Limited
The main business activity of Crescent Bioformulations is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Crescent Bioformulations Private Limited
Crescent Bioformulations Private Limited is audited by R SINGH & COMPANY for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R SINGH & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Crescent Bioformulations Private Limited
Crescent Bioformulations has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Bajpai | Director | 29 Jun 2021 | 5 Years 3 Months | Current |
| Anurag Mishra Also directs: Chemaxon Biosis Private Limited | Director | 04 Dec 2017 | 8 Years 10 Months | Current |
| Sagar Mishra Also directs: Chemaxon Biosis Private Limited | Director | 11 Oct 2011 | 14 Years 11 Months | Current |
Financials of Crescent Bioformulations Private Limited FY 2025 filings available
Crescent Bioformulations Private Limited reported revenue of ₹5.47 Cr (up 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Crescent Bioformulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 9% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Crescent Bioformulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹71.65 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3,000 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Crescent Bioformulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Crescent Bioformulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Crescent Bioformulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Crescent Bioformulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2025 | Bank of India | ₹2 Cr | Open |
| 26 Feb 2024 | Hdfc Bank Limited | ₹13.8 Lakh | Open |
| 28 Dec 2023 | Sidbi | ₹1 Cr | Satisfied |
| 01 Dec 2021 | Sidbi | ₹38.5 Lakh | Satisfied |
| 04 Aug 2020 | Sidbi | ₹1.5 Cr | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Crescent Bioformulations Private Limited
Employment history and EPFO contributions of people linked to Crescent Bioformulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Crescent Bioformulations Private Limited
Crescent Bioformulations has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECC6231G1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
| 09AAECC7515K1ZF | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Crescent Bioformulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Crescent Bioformulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Crescent Bioformulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Crescent Bioformulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Crescent Bioformulations Private Limited
Frequently Asked Questions about Crescent Bioformulations Private Limited
Crescent Bioformulations is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 11 October 2011 (15+ years old) and is registered under CIN U24233UP2011PTC046931.
Crescent Bioformulations reported revenue of ₹5.47 Cr for FY 2024 (up 9% YoY).
Crescent Bioformulations has 3 current directors:
- Anurag Bajpai - Director
- Anurag Mishra - Director
- Sagar Mishra - Director
Crescent Bioformulations reported a net profit of ₹3,000 (net margin 0%) and EBITDA of ₹71.65 Lakh (EBITDA margin 13.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Crescent Bioformulations is 6% over three years and 10% over five years. In the latest year (FY 2024) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Crescent Bioformulations is 09AAECC6231G1ZT, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAECC7515K1ZF (Uttar Pradesh).
The CIN (Corporate Identification Number) of Crescent Bioformulations is U24233UP2011PTC046931. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crescent Bioformulations was incorporated on 11 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
Crescent Bioformulations can be reached through the website crescentbioformulations.com. Its registered office is in Kanpur, Uttar Pradesh, India.